Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -20.56%-25.02M | ---- | 60.70%-20.75M | ---- | -178.60%-52.8M | ---- | 110.10%67.18M | ---- | -1,293.07%-665.37M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -20.31%-2.37M | ---- | -8.07%-1.97M | ---- | -144.89%-1.82M | ---- | 59.96%-744K | ---- | -4.09%-1.86M |
| Attributable subsidiary (profit) loss | ---- | 14.29%8K | ---- | 100.90%7K | ---- | -6,591.67%-779K | ---- | 0.00%12K | ---- | -89.29%12K |
| Impairment and provisions: | ---- | -114.93%-2.95M | ---- | -113.12%-1.37M | ---- | 109.95%10.47M | ---- | -79,215.04%-105.22M | ---- | 104.13%133K |
| -Other impairments and provisions | ---- | -114.93%-2.95M | ---- | -113.12%-1.37M | ---- | 109.95%10.47M | ---- | -79,215.04%-105.22M | ---- | 104.13%133K |
| Revaluation surplus: | ---- | 131.13%1.38M | ---- | -125.37%-4.43M | ---- | 431.63%17.45M | ---- | -67.33%3.28M | ---- | 30.79%10.05M |
| -Other fair value changes | ---- | 131.13%1.38M | ---- | -125.37%-4.43M | ---- | 431.63%17.45M | ---- | -67.33%3.28M | ---- | 30.79%10.05M |
| Asset sale loss (gain): | ---- | ---- | ---- | ---173K | ---- | ---- | ---- | ---- | ---- | 85.29%-10K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---173K | ---- | ---- | ---- | ---- | ---- | 85.29%-10K |
| Depreciation and amortization: | ---- | -4.62%1.49M | ---- | 6.85%1.56M | ---- | -7.24%1.46M | ---- | -6.86%1.57M | ---- | 2.61%1.69M |
| Financial expense | ---- | 2.43%1.44M | ---- | 6.45%1.4M | ---- | -7.97%1.32M | ---- | 12.41%1.43M | ---- | -11.17%1.27M |
| Unrealized exchange loss (gain) | ---- | -9.51%2.19M | ---- | -22.07%2.42M | ---- | -78.67%3.1M | ---- | 553.10%14.55M | ---- | ---3.21M |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --626.13M |
| Operating profit before the change of operating capital | ---- | -2.29%-23.84M | ---- | -7.84%-23.31M | ---- | -20.48%-21.61M | ---- | 42.44%-17.94M | ---- | 25.72%-31.17M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | -2,095.14%-6.32M | ---- | -311.76%-288K | ---- | -79.30%136K | ---- | 508.33%657K | ---- | -85.54%108K |
| Accounts payable increase (decrease) | ---- | -206.13%-5.85M | ---- | 188.63%5.51M | ---- | 151.51%1.91M | ---- | -1,293.23%-3.71M | ---- | -203.10%-266K |
| Cash from business operations | ---- | -99.13%-36.01M | ---- | 7.58%-18.08M | ---- | 6.77%-19.57M | ---- | 33.00%-20.99M | ---- | 23.52%-31.32M |
| Special items of business | 5.30%-20.35M | ---- | -90.10%-21.49M | ---- | 37.68%-11.3M | ---- | -19.22%-18.13M | ---- | -9.18%-15.21M | ---- |
| Net cash from operations | 5.30%-20.35M | -99.13%-36.01M | -90.10%-21.49M | 7.58%-18.08M | 37.68%-11.3M | 6.77%-19.57M | -19.22%-18.13M | 33.00%-20.99M | -9.18%-15.21M | 23.52%-31.32M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 20.47%2.35M | ---- | 8.08%1.95M | ---- | 147.67%1.81M | ---- | -60.30%730K | ---- | 3.78%1.84M |
| Sale of fixed assets | ---- | ---- | ---- | --194K | ---- | ---- | ---- | ---- | ---- | -51.47%33K |
| Purchase of fixed assets | ---- | 75.23%-80K | ---- | -487.27%-323K | ---- | 63.33%-55K | ---- | -219.15%-150K | ---- | 94.52%-47K |
| Other items in the investment business | -14.87%-2.9M | 23.92%-7.82M | 11.92%-2.53M | -40.73%-10.28M | 7.51%-2.87M | -132.89%-7.3M | -111.58%-3.1M | 468.64%22.21M | 2,106.14%26.8M | 21.34%-6.02M |
| Net cash from investment operations | -14.87%-2.9M | 34.40%-5.55M | 11.92%-2.53M | -52.30%-8.45M | 7.51%-2.87M | -124.36%-5.55M | -111.58%-3.1M | 642.68%22.79M | 2,106.14%26.8M | 28.39%-4.2M |
| Net cash before financing | 3.17%-23.25M | -56.59%-41.56M | -69.44%-24.01M | -5.65%-26.54M | 33.27%-14.17M | -1,495.39%-25.12M | -283.20%-21.24M | 105.07%1.8M | 175.93%11.59M | 24.13%-35.52M |
| Cash flow from financing activities | ||||||||||
| Interest paid - financing | ---- | 40.00%-45K | ---- | -97.37%-75K | ---- | 39.68%-38K | ---- | -57.50%-63K | ---- | 41.18%-40K |
| Other items of the financing business | 5.74%-690K | ---- | -133.84%-732K | ---- | 487.63%2.16M | ---- | -131.09%-558K | ---- | 362.04%1.8M | ---- |
| Net cash from financing operations | 5.74%-690K | -16.65%-1.46M | -133.84%-732K | -2.28%-1.26M | 487.63%2.16M | -4.25%-1.23M | -131.09%-558K | 14.21%-1.18M | 362.04%1.8M | -41.01%-1.37M |
| Effect of rate | 32.14%74K | 108.33%4K | 101.69%56K | 58.62%-48K | -137.11%-3.31M | 80.50%-116K | 5,002.86%8.93M | -234.92%-595K | 137.88%175K | -94.70%441K |
| Net Cash | 3.25%-23.94M | -54.79%-43.02M | -106.05%-24.75M | -5.50%-27.79M | 44.90%-12.01M | -4,328.57%-26.34M | -262.81%-21.8M | 101.69%623K | 183.92%13.39M | 22.80%-36.9M |
| Begining period cash | -39.51%65.85M | -20.36%108.87M | -20.36%108.87M | -16.22%136.71M | -16.22%136.71M | 0.02%163.17M | 0.02%163.17M | -18.26%163.14M | -18.26%163.14M | -16.51%199.59M |
| Cash at the end | -50.12%41.99M | -39.51%65.85M | -30.65%84.18M | -20.36%108.87M | -19.24%121.39M | -16.22%136.71M | -14.94%150.3M | 0.02%163.17M | -3.54%176.7M | -18.26%163.14M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Tianzhi Hong Kong Certified Public Accountants Limited | -- | Tianshi Hong Kong Certified Public Accountants Limited | -- | Guofu Haohua (Hong Kong) Certified Public Accountants Limited | -- | Deloitte Touche Tohmatsu CPA LLP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.